Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Cocaine hydrochloride 40 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cocaine hydrochloride |
Inferred relationship |
Some |
|
Cocaine hydrochloride powder BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cocaine hydrochloride |
Inferred relationship |
Some |
|
Cocaine hydrochloride 2.5% single-use solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cocaine hydrochloride |
Inferred relationship |
Some |
|
Cocaine hydrochloride 10% single-use solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cocaine hydrochloride |
Inferred relationship |
Some |
|
Cocaine hydrochloride 4% topical solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cocaine hydrochloride |
Inferred relationship |
Some |
|
Cocaine hydrochloride 10% topical solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cocaine hydrochloride |
Inferred relationship |
Some |
|
Cocaine viscous 4% topical solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cocaine hydrochloride |
Inferred relationship |
Some |
|
Cocaine viscous 10% topical solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cocaine hydrochloride |
Inferred relationship |
Some |
|
Cocaine hydrochloride 2.5% conventional release eye solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cocaine hydrochloride |
Inferred relationship |
Some |
|
Cocaine hydrochloride 10% conventional release eye solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cocaine hydrochloride |
Inferred relationship |
Some |
|
Cocaine viscous 10% conventional release cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cocaine hydrochloride |
Inferred relationship |
Some |
|
Cocaine viscous 4% conventional release cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cocaine hydrochloride |
Inferred relationship |
Some |
|
Cocaine hydrochloride 40 mg/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cocaine hydrochloride |
Inferred relationship |
Some |
1 |
Cocaine hydrochloride 40 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cocaine hydrochloride |
Inferred relationship |
Some |
1 |
Cocaine (as cocaine hydrochloride) 20 mg/mL and homatropine hydrobromide 20 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cocaine hydrochloride |
Inferred relationship |
Some |
2 |
Cocaine hydrochloride 40 mg/mL cutaneous solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cocaine hydrochloride |
Inferred relationship |
Some |
1 |
Cocaine hydrochloride 40 mg/mL cutaneous solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely cocaine (as cocaine hydrochloride) 50 milligram/1 milliliter and epinephrine 200 microgram/1 milliliter conventional release eye solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cocaine hydrochloride |
Inferred relationship |
Some |
1 |
Cocaine (as cocaine hydrochloride) 200 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely cocaine (as cocaine hydrochloride) 40 milligram/1 milliliter conventional release eye solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely cocaine (as cocaine hydrochloride) 50 milligram/1 milliliter conventional release eye solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cocaine hydrochloride |
Inferred relationship |
Some |
1 |